Statistics for NewAmsterdam Pharma Company N.V. (id:6662 NAMS)
Valuation metrics
Market cap
2.31B
Enterprise value
1.88B
Trailing P/E (ttm)
-9.40
Forward P/E
-13.21
PEG ratio
-13.21
Price/Sales (ttm)
68.67
Price/Book (mrq)
6.07
Enterprise Value/Revenue
56.10
Enterprise Value/EBITDA
-10.24
Overview
Shares outstanding
92.39M
Float
36.26M
Shares short
718.04K
% Held by insiders
0.00%
% Held by institutions
0.85%
Average volume (10 days)
565.60K
Average volume (90 days)
Price summary
52-Week low
8.90
52-Week high
26.35
52-Week change
51.19%
Beta
0.00
50-Day moving average
18.18
200-Day moving average
19.40
Dividends and splits
Forward annual dividend rate
1.32
Forward annual dividend yield
0.07
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
September 29th, 2022
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-85.89%
Operational effectiveness
Return on assets
-29.27%
Return on equity
-47.37%
Income statement
Revenue (ttm)
0.37
Revenue per share (ttm)
0.37
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-184,059,008.00
Net income to common (ttm)
-198,916,000.00
Diluted EPS (ttm)
-2.24
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
422.73M
Total cash per share (mrq)
4.58
Total debt (mrq)
506.00K
Total Debt/Equity (mrq)
0.13
Current ratio (mrq)
1.06K%
Book value per share (mrq)
4.11
Cash flow
Cash flow statement
-154,156,992.00
Levered free cash flow (LFCF)
-108,734,752.00